• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给小鼠注射MPTP会改变fosB和rgs9剪接异构体的比例。

MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9.

作者信息

Potashkin Judith A, Kang Un Jung, Loomis Patricia A, Jodelka Francine M, Ding Yunmin, Meredith Gloria E

机构信息

Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA.

出版信息

Brain Res. 2007 Nov 28;1182:1-10. doi: 10.1016/j.brainres.2007.08.080. Epub 2007 Sep 14.

DOI:10.1016/j.brainres.2007.08.080
PMID:17936734
Abstract

Most cases of Parkinson's disease (PD) are sporadic, suggesting an environmental influence on individuals affected by this neurodegenerative disorder. Environmental stresses often lead to changes in the regulation of splicing of pre-mRNA transcripts and this may lead to the pathogenesis of the disease. A 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/probenecid mouse model was used to examine the changes in the splicing of the fosB and rgs9 transcripts. The ratio of DeltafosB/fosB transcript was decreased in the substantia nigra and unchanged in the striatum after acute MPTP treatment. The DeltafosB/fosB transcript ratio decreased initially and then increased in the striatum of chronically MPTP-treated animals due to different degrees of reduction for the splice variants over time, whereas the ratio was unchanged in the substantia nigra. The ratio of rgs9-2/rgs9-1 transcript decreased in the substantia nigra of mice after acute MPTP treatment and increased temporarily in the striatum after chronic MPTP treatment. There was an increase in the DeltaFosB/FosB and RGS9-2/RGS9-1 protein ratios 3 weeks and 3 days post-treatment, respectively, in chronically treated mice. The data indicate that the pattern of splice isoforms of fosB and rgs9 reflects the brain's immediate and long-term responses to the physiological stress associated with Parkinsonism.

摘要

大多数帕金森病(PD)病例是散发性的,这表明环境因素会影响受这种神经退行性疾病影响的个体。环境压力常常导致前体信使核糖核酸(pre-mRNA)转录本剪接调控的变化,这可能会导致疾病的发病机制。使用1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)/丙磺舒小鼠模型来研究fosB和rgs9转录本剪接的变化。急性MPTP处理后,黑质中DeltafosB/fosB转录本的比例降低,纹状体中该比例未变。在长期接受MPTP处理的动物的纹状体中,由于剪接变体随时间不同程度的减少,DeltafosB/fosB转录本比例最初降低,然后升高,而在黑质中该比例未变。急性MPTP处理后,小鼠黑质中rgs9-2/rgs9-1转录本的比例降低,慢性MPTP处理后,纹状体中该比例暂时升高。在长期处理的小鼠中,处理后3周和3天,DeltaFosB/FosB和RGS9-2/RGS9-1蛋白比例分别增加。数据表明,fosB和rgs9的剪接异构体模式反映了大脑对与帕金森症相关的生理应激的即时和长期反应。

相似文献

1
MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9.给小鼠注射MPTP会改变fosB和rgs9剪接异构体的比例。
Brain Res. 2007 Nov 28;1182:1-10. doi: 10.1016/j.brainres.2007.08.080. Epub 2007 Sep 14.
2
Decreased RGS9 protein level in the striatum of rodents undergoing MPTP or 6-OHDA neurotoxicity.纹状体中 RGS9 蛋白水平降低的啮齿动物在 MPTP 或 6-OHDA 神经毒性作用下。
Neurosci Lett. 2010 Aug 2;479(3):231-5. doi: 10.1016/j.neulet.2010.05.068. Epub 2010 Jun 1.
3
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.多巴胺能神经传递的慢性改变会导致啮齿动物和灵长类动物纹状体中类deltaFosB蛋白持续升高。
Eur J Neurosci. 1996 Feb;8(2):365-81. doi: 10.1111/j.1460-9568.1996.tb01220.x.
4
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
5
Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.在帕金森病的渐进性MPTP小鼠模型中,运动干预可恢复运动缺陷,但不能恢复黑质纹状体的损伤。
Neuroscience. 2015 Jul 23;299:156-74. doi: 10.1016/j.neuroscience.2015.04.069. Epub 2015 May 2.
6
Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.雷帕霉素和海藻糖联合治疗在 MPTP 诱导的帕金森病小鼠模型中诱导自噬的治疗作用。
Pharmacol Biochem Behav. 2019 Feb;177:1-11. doi: 10.1016/j.pbb.2018.12.005. Epub 2018 Dec 21.
7
Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.社交丰富化可减轻黑质纹状体损伤,并逆转进行性 1-甲基-2-苯基-1,2,3,6-四氢吡啶(MPTP)帕金森病小鼠模型的运动障碍。
Neurobiol Dis. 2012 Mar;45(3):1051-67. doi: 10.1016/j.nbd.2011.12.024. Epub 2011 Dec 14.
8
Neuroprotection in Parkinson models varies with toxin administration protocol.帕金森病模型中的神经保护作用因毒素给药方案而异。
Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x.
9
MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.(R)-氯胺酮经鼻腔给药后可减轻小鼠脑内 MPTP 诱导的多巴胺能神经毒性:TrkB 信号的作用。
Psychopharmacology (Berl). 2020 Jan;237(1):83-92. doi: 10.1007/s00213-019-05346-5. Epub 2019 Aug 15.
10
Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.帕金森病MPTP小鼠模型中的脑改变——一项免疫细胞化学研究
J Neural Transm (Vienna). 2003 Oct;110(10):1129-44. doi: 10.1007/s00702-003-0021-y.

引用本文的文献

1
Endurance exercise training suppresses myostatin upregulation and nuclear factor-kappa B activation in a mouse model of Parkinson's disease.耐力运动训练可抑制帕金森病小鼠模型中肌肉生长抑制素的上调和核因子-κB的激活。
Vet World. 2022 Feb;15(2):383-389. doi: 10.14202/vetworld.2022.383-389. Epub 2022 Feb 18.
2
Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease.白细胞介素-1β和肿瘤坏死因子-α在慢性/进行性帕金森病小鼠模型骨骼肌中的上调和核因子κB 的激活。
Med Sci Monit. 2018 Oct 22;24:7524-7531. doi: 10.12659/MSM.909032.
3
Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study.
帕金森病诱发与凋亡介质P53和活性半胱天冬酶-3的心脏上调之间的关联:一项免疫组织化学研究
Med Sci Monit Basic Res. 2018 Aug 23;24:120-126. doi: 10.12659/MSMBR.910307.
4
FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.急性神经毒物暴露后,在含有不同易感性多巴胺神经元的脑区中FosB和ΔFosB的表达。
Brain Res. 2016 Oct 15;1649(Pt A):53-66. doi: 10.1016/j.brainres.2016.08.030. Epub 2016 Aug 24.
5
e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease.E-钙黏蛋白在1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病中的作用
Mediators Inflamm. 2016;2016:3937057. doi: 10.1155/2016/3937057. Epub 2016 Apr 17.
6
Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.帕金森病和非典型帕金森综合征患者的生物标志物。
PLoS One. 2012;7(8):e43595. doi: 10.1371/journal.pone.0043595. Epub 2012 Aug 27.
7
DEGAS: de novo discovery of dysregulated pathways in human diseases.DEGAS:人类疾病中失调途径的从头发现。
PLoS One. 2010 Oct 19;5(10):e13367. doi: 10.1371/journal.pone.0013367.
8
SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.SRRM2,一种可能的血液生物标志物,揭示帕金森病中的高选择性剪接。
PLoS One. 2010 Feb 8;5(2):e9104. doi: 10.1371/journal.pone.0009104.
9
Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol.在小鼠中模拟帕金森病发病机制:慢性MPTP方案的优势
Parkinsonism Relat Disord. 2008;14 Suppl 2(Suppl 2):S112-5. doi: 10.1016/j.parkreldis.2008.04.012. Epub 2008 Jun 27.